61 – 70 of 391
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Incretin hormone receptors are required for normal beta cell development and function in female mice
(
- Contribution to journal › Article
-
Mark
Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes
(
- Contribution to journal › Article
-
Mark
Evidence for neural contribution to islet effects of DPP-4 inhibition in mice
(
- Contribution to journal › Article
-
Mark
Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis.
(
- Contribution to journal › Article
- 2015
-
Mark
Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.
(
- Contribution to journal › Article
-
Mark
Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.
(
- Contribution to journal › Article
-
Mark
Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
(
- Contribution to journal › Article
-
Mark
Deciphering the hypoglycemic glucagon response: development of a graded hyperinsulinemic hypoglycemic clamp technique in female mice.
(
- Contribution to journal › Article
-
Mark
Fibroblast growth factor 21 prevents glycemic deterioration in insulin deficient mouse models of diabetes.
(
- Contribution to journal › Article
-
Mark
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story? Reply to Bastard JP, Rabasa-Lhoret R, Laville M and Disse E [letter]
(
- Contribution to journal › Letter